These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21028985)

  • 21. Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia.
    Pradines B; Bertaux L; Pomares C; Delaunay P; Marty P
    Malar J; 2011 Sep; 10():268. PubMed ID: 21923936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrahost modeling of artemisinin resistance in Plasmodium falciparum.
    Saralamba S; Pan-Ngum W; Maude RJ; Lee SJ; Tarning J; Lindegårdh N; Chotivanich K; Nosten F; Day NP; Socheat D; White NJ; Dondorp AM; White LJ
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):397-402. PubMed ID: 21173254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
    Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
    Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
    Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
    Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.
    Lanteri CA; Chaorattanakawee S; Lon C; Saunders DL; Rutvisuttinunt W; Yingyuen K; Bathurst I; Ding XC; Tyner SD
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5831-40. PubMed ID: 25049252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates.
    Rutvisuttinunt W; Chaorattanakawee S; Tyner SD; Teja-Isavadharm P; Se Y; Yingyuen K; Chaichana P; Bethell D; Walsh DS; Lon C; Fukuda M; Socheat D; Noedl H; Schaecher K; Saunders DL
    Malar J; 2012 Sep; 11():325. PubMed ID: 22974086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Surveillance of Pfkelch13 and Pfmdr1 Mutations in Plasmodium falciparum Isolates from Southern Thailand.
    Khammanee T; Sawangjaroen N; Buncherd H; Tun AW; Thanapongpichat S
    Korean J Parasitol; 2019 Aug; 57(4):369-377. PubMed ID: 31533403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.
    Mukherjee A; Bopp S; Magistrado P; Wong W; Daniels R; Demas A; Schaffner S; Amaratunga C; Lim P; Dhorda M; Miotto O; Woodrow C; Ashley EA; Dondorp AM; White NJ; Wirth D; Fairhurst R; Volkman SK
    Malar J; 2017 May; 16(1):195. PubMed ID: 28494763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial.
    Bethell D; Se Y; Lon C; Tyner S; Saunders D; Sriwichai S; Darapiseth S; Teja-Isavadharm P; Khemawoot P; Schaecher K; Ruttvisutinunt W; Lin J; Kuntawungin W; Gosi P; Timmermans A; Smith B; Socheat D; Fukuda MM
    PLoS One; 2011; 6(5):e19283. PubMed ID: 21603629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.
    Phyo AP; Nkhoma S; Stepniewska K; Ashley EA; Nair S; McGready R; ler Moo C; Al-Saai S; Dondorp AM; Lwin KM; Singhasivanon P; Day NP; White NJ; Anderson TJ; Nosten F
    Lancet; 2012 May; 379(9830):1960-6. PubMed ID: 22484134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.
    Alker AP; Lim P; Sem R; Shah NK; Yi P; Bouth DM; Tsuyuoka R; Maguire JD; Fandeur T; Ariey F; Wongsrichanalai C; Meshnick SR
    Am J Trop Med Hyg; 2007 Apr; 76(4):641-7. PubMed ID: 17426163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
    Lim P; Wongsrichanalai C; Chim P; Khim N; Kim S; Chy S; Sem R; Nhem S; Yi P; Duong S; Bouth DM; Genton B; Beck HP; Gobert JG; Rogers WO; Coppee JY; Fandeur T; Mercereau-Puijalon O; Ringwald P; Le Bras J; Ariey F
    Antimicrob Agents Chemother; 2010 May; 54(5):2135-42. PubMed ID: 20194689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.
    Price RN; Uhlemann AC; Brockman A; McGready R; Ashley E; Phaipun L; Patel R; Laing K; Looareesuwan S; White NJ; Nosten F; Krishna S
    Lancet; 2004 Jul 31-Aug 6; 364(9432):438-447. PubMed ID: 15288742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Geographic expansion of artemisinin resistance.
    Müller O; Lu GY; von Seidlein L
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30995310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.
    Amato R; Lim P; Miotto O; Amaratunga C; Dek D; Pearson RD; Almagro-Garcia J; Neal AT; Sreng S; Suon S; Drury E; Jyothi D; Stalker J; Kwiatkowski DP; Fairhurst RM
    Lancet Infect Dis; 2017 Feb; 17(2):164-173. PubMed ID: 27818095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
    Falq G; Van Den Bergh R; De Smet M; Etienne W; Nguon C; Rekol H; Imwong M; Dondorp A; Kindermans JM
    Malar J; 2016 Sep; 15(1):446. PubMed ID: 27585957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.